Release of potential immunomodulatory factors during platelet storage

Transfusion

Volumn 46, Issue 7, 2006, Pages 1184-1189

  Cognasse, Fabrice ^b   Boussoulade, Françoise ^b   Chavarin, Patricia ^b   Acquart, Sophie ^b   Fabrigli, Patrick ^b   Lamy, Bernard ^b   Garraud, Olivier ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR AA; RANTES; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; B LYMPHOCYTE ACTIVATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; THROMBOCYTE; THROMBOCYTE PRESERVATION;

BLOOD PLATELETS; BLOOD PRESERVATION; CD40 LIGAND; CYTAPHERESIS; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKINS; PLATELET TRANSFUSION; PLATELET-DERIVED GROWTH FACTOR; RANTES; TIME FACTORS;

EID: 33746492285     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00869.x     Document Type: Article

References (29)

1. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002;22:913-22.
2. Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp Hematol 2004;32:135-9.
3. Danese S, de la Motte C, Reyes BM, et al. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 2004;172:2011-5.
4. Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity: A communication link between innate and adaptive immune compartments. Immunity 2003;19:9-19.
5. Kimata H, Yoshida A, Ishioka C, et al. RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996;183:2397-402.
6. Liu CY, Battaglia M, Lee SH, et al. Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25-(nonregulatory) T cells. J Immunol 2005;174:2680-6.
7. George JN. Platelets. Lancet 2000;355:1531-9.
8. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-62.
9. Rozman P. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transpl Immunol 2002;10:165-81.
10. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002;106:896-9.
11. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001;357:2023-4.
12. Banchereau J, de Paoli P, Valle A, et al. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991;251:70-2.
13. Banchereau J, Rousset F. Growing human B lymphocytes in the CD40 system. Nature 1991;353:678-9.
14. Armitage RJ, Maliszewski CR, Alderson MR, et al. CD40L: a multi-functional ligand. Semin Immunol 1993;5:401-12.
15. Guide to the preparation, use and quality assurance of blood components. Strasbourg; Council of Europe; 2005.
16. Gear AR, Camerini D. Platelet chemokines and chemokine receptors, linking hemostasis, inflammation, and host defense. Microcirculation 2003;10:335-50.
17. Wagner T, Vetter A, Dimovic N, et al. Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution. Transfusion 2002;42:719-27.
18. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004;25:489-95.
19. Briere F, Defrance T, Vanbervliet B, et al. Transforming growth factor beta (TGF beta) directs IgA1 and IgA2 switching in human naive B cells. Adv Exp Med Biol 1995;371A:21-6.
20. Garraud O, Diouf A, Holm I, et al. Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II: induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with MSP119. Immunology 1999;97:497-505.
21. Garraud O, Diouf A, Nguer CM, et al. Different Plasmodium falciparum recombinant MSP1 (19) antigens differ in their capacities to stimulate in vitro peripheral blood T lymphocytes in individuals from various endemic areas. Scand J Immunol 1999;49:431-40.
22. Wagner M, Poeck H, Jahrsdoerfer B, et al. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol 2004;172:954-63.
23. Langer F, Ingersoll SB, Amirkhosravi A, et al. The role of CD40 in CD40L- and antibody-mediated platelet activation. Thromb Haemost 2005;93:1137-46.
24. Mazzei GJ, Edgerton MD, Losberger C, et al. Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem 1995;270:7025-8.
25. Barcellos-Hoff MH. Latency and activation in the control of TGF-beta. J Mammary Gland Biol Neoplasia 1996;1:353-63.
26. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000;11:59-69.
27. Lawrence DA. Transforming growth factor-beta: a general review. Eur Cytokine Netw 1996;7:363-74.
28. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
29. Hei DJ, Grass J, Lin L, et al. Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light. Transfusion 1999;39:239-48.